AU3057797A - Antibacterial agents - Google Patents

Antibacterial agents

Info

Publication number
AU3057797A
AU3057797A AU30577/97A AU3057797A AU3057797A AU 3057797 A AU3057797 A AU 3057797A AU 30577/97 A AU30577/97 A AU 30577/97A AU 3057797 A AU3057797 A AU 3057797A AU 3057797 A AU3057797 A AU 3057797A
Authority
AU
Australia
Prior art keywords
antibacterial agents
antibacterial
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30577/97A
Inventor
Meng-Hsin Chen
Ravi Nargund
H. Russell Onishi
Arthur A. Patchett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3057797A publication Critical patent/AU3057797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU30577/97A 1996-05-07 1997-05-02 Antibacterial agents Abandoned AU3057797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1678996P 1996-05-07 1996-05-07
US60016789 1996-05-07
PCT/US1997/007455 WO1997042179A1 (en) 1996-05-07 1997-05-02 Antibacterial agents

Publications (1)

Publication Number Publication Date
AU3057797A true AU3057797A (en) 1997-11-26

Family

ID=21778992

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30577/97A Abandoned AU3057797A (en) 1996-05-07 1997-05-02 Antibacterial agents

Country Status (3)

Country Link
US (1) US5925659A (en)
AU (1) AU3057797A (en)
WO (1) WO1997042179A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1143951A3 (en) * 1998-09-21 2002-02-06 University Of Florida Research Foundation, Inc. Antimalarial agents
EP1488791A3 (en) * 1998-09-21 2005-04-06 University Of Florida Research Foundation, Inc. Antimalarial agents
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
GB9914255D0 (en) * 1999-06-18 1999-08-18 Lilly Forschung Gmbh Pharmaceutical compounds
PT1251848E (en) * 2000-01-18 2004-10-29 Vertex Pharma GELASE INHIBITORS AND THEIR UTILIZATIONS
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US20050124021A1 (en) * 2000-06-14 2005-06-09 Newton Gerald L. Acetyl glucosaminyl inositol deacetylase, a mycothiol biosynthetic enzyme, and methods of use
DE60239316D1 (en) * 2001-01-16 2011-04-14 Univ Ramot HYBRID PEPTIDES FOR THE TREATMENT OF BACTERAEMY AND SEPSIS
CA2492035A1 (en) * 2002-07-11 2004-01-15 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
EA011808B1 (en) * 2003-01-08 2009-06-30 Новартис Вэксинес Энд Дайэгностикс, Инк. Antibacterial agents
US7638513B2 (en) 2004-06-02 2009-12-29 Schering Corporation Compounds for the treatment of inflammatory disorders
EP2338878A3 (en) 2005-12-15 2011-11-16 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
WO2008027466A1 (en) 2006-08-31 2008-03-06 Schering Corporation Hydantoin derivatives useful as antibacterial agents
CN107021895A (en) * 2007-06-12 2017-08-08 尔察祯有限公司 Antiseptic
WO2009158369A1 (en) 2008-06-25 2009-12-30 Schering Corporation Synthesis and use of heterocyclic antibacterial agents
AU2009279949A1 (en) * 2008-08-04 2010-02-11 Merck Sharp & Dohme Corp. Urea derivatives as antibacterial agents
WO2010024356A1 (en) * 2008-08-27 2010-03-04 大正製薬株式会社 Novel hydroxamic acid derivative having naphthyridine-n-oxide
WO2010100475A1 (en) * 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
WO2011005355A1 (en) * 2009-05-07 2011-01-13 Achaogen, Inc. Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
WO2012031298A2 (en) 2010-09-03 2012-03-08 Duke University Ethynylbenzene derivatives
AR083760A1 (en) 2010-11-10 2013-03-20 Achaogen Inc ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
KR101946107B1 (en) * 2012-08-25 2019-02-08 욱크하르트 리미티드 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
US10647664B2 (en) 2013-08-16 2020-05-12 Duke University Substituted hydroxamic acid compounds
WO2015024021A2 (en) 2013-08-16 2015-02-19 Duke University Antibacterial compounds
US9908851B2 (en) 2013-08-16 2018-03-06 Duke University 2-piperidinyl substituted N,3-dihydroxybutanamides
CN103923029B (en) * 2014-03-13 2016-03-09 吴文君 A kind of dihydro-oxazole class microbiotic and preparation method thereof
CN104817512B (en) * 2015-05-04 2016-09-21 吉林百年汉克制药有限公司 A kind of synthetic method of oxazolines pharmaceutical intermediate compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2714082A (en) * 1955-07-26 New oxazoline derivatives
US2772281A (en) * 1954-12-23 1956-11-27 Merck & Co Inc Synthesis of 4-amino-3-isoxazolidone and its derivatives
US2840565A (en) * 1954-12-23 1958-06-24 Merck & Co Inc Optical isomers of 4-amino-3-isoxazolidone
US3709992A (en) * 1966-12-07 1973-01-09 Us Rubber Co Fungicidal use of certain carboxamidothiazoles
DE1642005A1 (en) * 1967-07-20 1971-04-29 Dynamit Nobel Ag Use of new cyclic N-S compounds as bacterostatics and fungistats
US4061749A (en) * 1976-07-06 1977-12-06 Shell Oil Company 5,6-Dihydro-4H-1,3-thiazine-2-carboxaldehyde oxime useful as insecticides
US4565654A (en) * 1983-03-28 1986-01-21 University Of Notre Dame Du Lac N-Acyloxy monocyclic β-lactams
US5283275A (en) * 1990-06-28 1994-02-01 Becton, Dickinson And Company Clarifiers for polyolefins and polyolefin compositions containing same

Also Published As

Publication number Publication date
US5925659A (en) 1999-07-20
WO1997042179A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
AU3057797A (en) Antibacterial agents
AU690054B2 (en) Earmuff-eyeglass combination
AU2784397A (en) Contrast agents
AU4040197A (en) Microturbomachinery
AU3387997A (en) Autonotification
AU2845197A (en) Cycloalkano-pyridines
AU4013397A (en) Arylalkanoylpyridazines
AU4176997A (en) 3-alkyl-3-phenyl-piperidines
AU2684197A (en) Handleset
AU4218597A (en) Superseat
AU3499397A (en) Antibacterial composition
AU3701397A (en) Anti-herpesviral agent
AU2090897A (en) Hydroxyhexahydropyridazines
AU3620297A (en) Substituted triazoloazinesulphonamides
AU3581497A (en) Novel antibacterial compounds
AU3130597A (en) Tristetraprolin
AU3307399A (en) Novel antibacterial agents
AU3554995A (en) Antipicornaviral agents
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
AU2237197A (en) Fishing-lure
AU4332497A (en) Endo-beta-galactosidase
AU1900097A (en) Cremators
AU2955597A (en) Substituted phenyluracils
AU3557397A (en) Double-tau-profile